430 related articles for article (PubMed ID: 23357205)
1. Folic acid-conjugated graphene oxide for cancer targeted chemo-photothermal therapy.
Qin XC; Guo ZY; Liu ZM; Zhang W; Wan MM; Yang BW
J Photochem Photobiol B; 2013 Mar; 120():156-62. PubMed ID: 23357205
[TBL] [Abstract][Full Text] [Related]
2. Redox-responsive biodegradable PEGylated nanographene oxide for efficiently chemo-photothermal therapy: a comparative study with non-biodegradable PEGylated nanographene oxide.
Xiong H; Guo Z; Zhang W; Zhong H; Liu S; Ji Y
J Photochem Photobiol B; 2014 Sep; 138():191-201. PubMed ID: 24976623
[TBL] [Abstract][Full Text] [Related]
3. Smart pH-responsive nanocarriers based on nano-graphene oxide for combined chemo- and photothermal therapy overcoming drug resistance.
Feng L; Li K; Shi X; Gao M; Liu J; Liu Z
Adv Healthc Mater; 2014 Aug; 3(8):1261-71. PubMed ID: 24652715
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effect of chemo-photothermal therapy using PEGylated graphene oxide.
Zhang W; Guo Z; Huang D; Liu Z; Guo X; Zhong H
Biomaterials; 2011 Nov; 32(33):8555-61. PubMed ID: 21839507
[TBL] [Abstract][Full Text] [Related]
5. Reduced graphene oxide coated Cu
Zhen SJ; Wang TT; Liu YX; Wu ZL; Zou HY; Huang CZ
J Photochem Photobiol B; 2018 Mar; 180():9-16. PubMed ID: 29413707
[TBL] [Abstract][Full Text] [Related]
6. Triformyl cholic acid and folic acid functionalized magnetic graphene oxide nanocomposites: Multiple-targeted dual-modal synergistic chemotherapy/photothermal therapy for liver cancer.
Gong T; Wang X; Ma Q; Li J; Li M; Huang Y; Liang W; Su D; Guo R
J Inorg Biochem; 2021 Oct; 223():111558. PubMed ID: 34329998
[TBL] [Abstract][Full Text] [Related]
7. Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs.
Zhang L; Xia J; Zhao Q; Liu L; Zhang Z
Small; 2010 Feb; 6(4):537-44. PubMed ID: 20033930
[TBL] [Abstract][Full Text] [Related]
8. The effect of ligand density on in vivo tumor targeting of nanographene oxide.
Lee JH; Sahu A; Jang C; Tae G
J Control Release; 2015 Jul; 209():219-28. PubMed ID: 25937319
[TBL] [Abstract][Full Text] [Related]
9. Fabrication and characterization of a triple functionalization of graphene oxide with Fe3O4, folic acid and doxorubicin as dual-targeted drug nanocarrier.
Wang Z; Zhou C; Xia J; Via B; Xia Y; Zhang F; Li Y; Xia L
Colloids Surf B Biointerfaces; 2013 Jun; 106():60-5. PubMed ID: 23434692
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effect of chemo-photothermal for breast cancer therapy using folic acid (FA) modified zinc oxide nanosheet.
Vimala K; Shanthi K; Sundarraj S; Kannan S
J Colloid Interface Sci; 2017 Feb; 488():92-108. PubMed ID: 27821343
[TBL] [Abstract][Full Text] [Related]
11. Facile fabrication of a near-infrared responsive nanocarrier for spatiotemporally controlled chemo-photothermal synergistic cancer therapy.
Wan H; Zhang Y; Liu Z; Xu G; Huang G; Ji Y; Xiong Z; Zhang Q; Dong J; Zhang W; Zou H
Nanoscale; 2014 Aug; 6(15):8743-53. PubMed ID: 24954159
[TBL] [Abstract][Full Text] [Related]
12. Folic acid-functionalized graphene oxide nanosheets via plasma etching as a platform to combine NIR anticancer phototherapy and targeted drug delivery.
Mauro N; Scialabba C; Agnello S; Cavallaro G; Giammona G
Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110201. PubMed ID: 31761243
[TBL] [Abstract][Full Text] [Related]
13. Multifunctional PEG-GO/CuS nanocomposites for near-infrared chemo-photothermal therapy.
Bai J; Liu Y; Jiang X
Biomaterials; 2014 Jul; 35(22):5805-13. PubMed ID: 24767788
[TBL] [Abstract][Full Text] [Related]
14. Folic acid-modified Prussian blue/polydopamine nanoparticles as an MRI agent for use in targeted chemo/photothermal therapy.
Lin X; Cao Y; Li J; Zheng D; Lan S; Xue Y; Yu F; Wu M; Zhu X
Biomater Sci; 2019 Jul; 7(7):2996-3006. PubMed ID: 31111139
[TBL] [Abstract][Full Text] [Related]
15. Photothermal effect and cytotoxicity of CuS nanoflowers deposited over folic acid conjugated nanographene oxide.
Neelgund GM; Oki A; Bandara S; Carson L
J Mater Chem B; 2021 Feb; 9(7):1792-1803. PubMed ID: 33393530
[TBL] [Abstract][Full Text] [Related]
16. Fabrication of multifunctional SiO2@GN-serum composites for chemo-photothermal synergistic therapy.
Liu Y; Bai J; Jia X; Jiang X; Guo Z
ACS Appl Mater Interfaces; 2015 Jan; 7(1):112-21. PubMed ID: 25474753
[TBL] [Abstract][Full Text] [Related]
17. "Gold nanoparticles composite-folic acid conjugated graphene oxide nanohybrids" for targeted chemo-thermal cancer ablation: In vitro screening and in vivo studies.
Chauhan G; Chopra V; Tyagi A; Rath G; Sharma RK; Goyal AK
Eur J Pharm Sci; 2017 Jan; 96():351-361. PubMed ID: 27721039
[TBL] [Abstract][Full Text] [Related]
18. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin Receptor-Mediated Tumor-Targeting Nanocarriers Based on Octreotide-PEG Conjugated Nanographene Oxide for Combined Chemo and Photothermal Therapy.
Zhang X; Yang C; Zhou J; Huo M
Small; 2016 Jul; 12(26):3578-90. PubMed ID: 27244649
[TBL] [Abstract][Full Text] [Related]
20. Folic acid-grafted bovine serum albumin decorated graphene oxide: An efficient drug carrier for targeted cancer therapy.
Ma N; Liu J; He W; Li Z; Luan Y; Song Y; Garg S
J Colloid Interface Sci; 2017 Mar; 490():598-607. PubMed ID: 27923144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
